From rare to common - investigating universal mechanisms of renal degeneration exemplified by defective MAPKBP1

The project is based on the investigation the poorly characterized multi-domain ciliopathy-protein MAPKBP1 (JNK-binding protein 1), which is located at ciliary basal bodies and centrosomes. Patients with mutations in this gene exhibit severe renal fibrosis and mild skelettal malformations. The overall aim of this project is to analyse the intracellular localization of MAPKBP1, to identify its interactome and explore its physiological roles in cellular signalling during the cell cycle.

Analysing the interplay of aberrant cytokine-producing B cells, T cells and plasma cells during colitis development

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, is a group of immune-mediated disorders of the intestine, characterized by aberrant cytokine production by a multitude of immune cells in response to the microbiota. The interplay of these immune cell subsets (B cells, plasma cells, T cells and myeloid cell populations) is highly complex and poorly understood. We will apply a systemic approach to define an overall lymphocyte profile of immune cell subsets which contribute to a pro-inflammatory setting during chronic and acute IBD.

Role of hepatic interleukin-1 receptor type 1 (IL-1R1) in inflammatory hepatocarcinogenesis

The prevalence of non-alcoholic fatty liver disease (NAFLD) has risen and in particular patients with the inflammatory subform NASH have an increased risk of developing hepatocellular carcinoma (HCC). Due to the overall mostly poor prognosis of HCC the development of new therapeutic approaches is of high clinical relevance.

A dimensional psychiatry approach to eating disorders using machine learning techniques on structural and functional neuroimaging data from multicenter studies.

My aim is to test the ‚dimensional‘ approach to classify psychiatric disorders. At present, the approach used in psychiatry is ‚categorical‘: each disorder is identified by a set of specific symptoms and is treated as a separated entity in therapy and research. To the contrary, the dimensional approach aims to identify basic mechanisms that can be disrupted to a different degree in each individual and, when this happens, might concur to an increased risk of psychiatric illness, across the whole spectrum of psychiatric disorders.

Differential effects of dietary sugar- and fat-induced overweight on hypoxia- and hyperoxia-associated pulmonary and cardiac changes and their modulation by the naturally occurring molecule spermidine.

Obese and diabetic patients frequently suffer from lung function impairment and chronic lung disease. This project aims at a better understanding of the structural and molecular alterations within pulmonary cells that are induced by high dietary intake of sugar or fat, and how these are affected by hypoxia and hyperoxia that can occur in the context of lung disease or therapeutic treatments. In this way we want to detect distinct pathomechanisms that can be used for novel therapeutic approaches.

Die funktionellen und molekularen Mechanismen der Tachykardie-induzierten Kardiomyopathie

Die Tachykardiomyopathie (TCM) bezeichnet eine Einschränkung der Herzfunktion, die durch zu hohe und/oder unregelmäßige Herzfrequenzen kausal bedingt ist. Aktuelle klinische Daten weisen darauf hin, dass die kausale Bedeutung von Herzrhythmusstörungen für die Entstehung einer Herzschwäche unterschätzt wird. Jedoch ist die Identifikation und damit die suffiziente Behandlung von Patienten mit TCM schwierig, da die Diagnose ex juvantibus gestellt wird und die (frühen) Mechanismen unverstanden sind.

Heidelberg Research College for Neurooncology: Resistance in brain tumours

Tumours in the brain are often difficult or poorly treatable. The reasons for this are the position in a crucial area of our bodies as well as molecular and structural characteristics of the tumours. In addition, changes of the tumours during treatment often reduces the effectiveness of therapies.     The sum of all factors which are limiting common treatments is referred to as drug resistance. Research into these factors as well as overcoming resistance is the main objective of the Heidelberg Research College for Neurooncology. 

Clinician Scientist Programme on Rare Important Syndromes in Endocrinology (RISE)

The clinician scientist programme focuses on orphan endocrine diseases of the hypothalamic pituitary adrenal (HPA) systems. These are rare and frequently remain unrecognised, in part because disease symptoms are non-specific and do not guide to underlying disease cause. Diagnosis and initiation of appropriate treatment may frequently delayed by years, leading to irreversible damage with devastating consequences. Therefore, clinician trainees must develop the awareness and acquire the skills to reach the correct diagnosis and institute corrective management and treatment.